相关实验视频
Updated: Jan 14, 2026

09:42
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
43.5K
兽医抗病毒免疫治疗中的单克隆抗体:技术,应用和挑战
Serkan Kökkaya1, Ayşe Gençay Göksu2, İbrahim Sözdutmaz2
1Faculty of Veterinary Medicine, Department of Virology, Yozgat Bozok University, Yozgat, Türkiye.
Veterinary research communications
|October 22, 2025
概括
单克隆抗体 (mAbs) 是兽医抗病毒疗法的前景,为动物病毒性疾病提供向治疗. 克服生产成本和病毒突变是它们广泛兽医应用的关键.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 单克隆抗体 (mAbs) 是用于人类医疗保健的特定免疫球蛋白,但在兽医中应用有限.
- 目前只有很少有许可的兽医mAb产品,大多数候选产品都处于临床前阶段.
- 兽医病毒病原体带来了诊断和治疗方面的挑战.
研究的目的:
- 审查针对兽医病毒病原体的中和mAbs.
- 讨论mAb生产技术的进步和相关的挑战.
- 探索mAbs在兽医和One Health框架中的潜力.
主要方法:
- 对兽医病毒病中和 mAbs 的综合文献综述.
- 分析生产技术,有效性和挑战.
- 评估当前和未来的动物卫生应用.
主要成果:
- 在mAb生产方面的创新旨在降低免疫性并提高疗效.
- 挑战包括高生产成本,物流和病毒逃生突变.
- 抗病毒mAbs对伴侣动物,牲畜和野生动物都有潜力.
结论:
- 如果解决挑战,抗病毒mAbs为兽医提供了重要的潜力.
- 整合到一个健康战略可以提高对动物性病毒威胁的准备.
- 进一步的技术进步和战略实施对于临床成功至关重要.
相关概念视频
Hybridoma Technology
17.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.2K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

